ORF3c
| ORF3c | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Organism | SARS-CoV-2 | ||||||
| Symbol | ORF3c | ||||||
| UniProt | P0DTG1 | ||||||
| |||||||
ORF3c is a gene found in coronaviruses of the subgenus Sarbecovirus , including SARS-CoV and SARS-CoV-2. It was first identified in the SARS-CoV-2 genome and encodes a 41 amino acid non-structural protein of unknown function.[1] [2] [3] It is also present in the SARS-CoV genome, but was not recognized until the identification of the SARS-CoV-2 homolog.[4]
Nomenclature
[edit ]There has been significant confusion in the scientific literature around the nomenclature used for the accessory proteins of SARS-CoV-2, especially several overlapping genes with ORF3a.[4] The predicted protein product of the ORF3c gene has at least once been referred to as "3b protein",[5] but it is not to be confused with the non-homologous gene ORF3b .[4] It has also been described under the names ORF3h[2] and ORF3a.iORF1.[6] The recommended nomenclature for SARS-CoV-2 uses the term ORF3c for this gene.[4]
Comparative genomics
[edit ]ORF3c is an overlapping gene whose open reading frame overlaps both ORF3a and ORF3d in the SARS-CoV-2 genome. This potentially represents a rare example of all three possible reading frames of the same sequence region encoding functional proteins.[7] [4]
Bioinformatics analyses of Sarbecovirus sequences suggest that the sequence and length of ORF3c are well conserved, indicating that it is likely to encode a functional protein.[1] [3] [2] It appears to be subject to purifying selection.[1] [7]
Properties
[edit ]Ribosome profiling experiments confirm that the ORF3c gene expresses a protein product.[6] The relatively short 41-residue protein is predicted to contain a transmembrane domain and has features suggestive of a viroporin.[2]
References
[edit ]- ^ a b c Firth AE (October 2020). "A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a". The Journal of General Virology. 101 (10): 1085–1089. doi:10.1099/jgv.0.001469. PMC 7660454 . PMID 32667280.
- ^ a b c d Cagliani R, Forni D, Clerici M, Sironi M (September 2020). "Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses". Infection, Genetics and Evolution. 83 104353. doi:10.1016/j.meegid.2020.104353. PMC 7199688 . PMID 32387562.
- ^ a b Jungreis I, Sealfon R, Kellis M (May 2021). "SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes". Nature Communications. 12 (1): 2642. doi:10.1038/s41467-021-22905-7. hdl:1721.1/130581 . PMC 8113528 . PMID 33976134.
- ^ a b c d e Jungreis I, Nelson CW, Ardern Z, Finkel Y, Krogan NJ, Sato K, et al. (June 2021). "Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution". Virology. 558: 145–151. doi:10.1016/j.virol.2021年02月01日3. hdl:1721.1/130363 . PMC 7967279 . PMID 33774510.
- ^ Pavesi A (July 2020). "New insights into the evolutionary features of viral overlapping genes by discriminant analysis". Virology. 546: 51–66. doi:10.1016/j.virol.202003007. PMC 7157939 . PMID 32452417.
- ^ a b Finkel Y, Mizrahi O, Nachshon A, Weingarten-Gabbay S, Morgenstern D, Yahalom-Ronen Y, et al. (January 2021). "The coding capacity of SARS-CoV-2". Nature. 589 (7840): 125–130. doi:10.1038/s41586-020-2739-1 . PMID 32906143.
- ^ a b Nelson CW, Ardern Z, Goldberg TL, Meng C, Kuo CH, Ludwig C, et al. (October 2020). "Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic". eLife. 9 e59633. doi:10.7554/eLife.59633 . PMC 7655111 . PMID 33001029.
